Oil dips as potential Fed rate hike overshadows falling stocks
..
Headlines
Headlines
..
Headlines
..
Headlines
..
Headlines
..
Headlines
..
Headlines
..
Headlines
..
Headlines
Investors are particularly interested in GSK’s future plans, given the pending loss of patent protection in 2027 for dolutegrav..
Headlines
..
Headlines
..
Headlines